Cart
sales@molnova.com
Disulfiram
CAS No. 97-77-8
Disulfiram( NSC 25953; Tetraethylthiuram disulfide )
Catalog No. M16885 CAS No. 97-77-8
Disulfiram is a specific inhibitor of aldehyde-dehydrogenase (ALDH1), used for the treatment of chronic alcoholism by producing an acute sensitivity to alcohol.
Purity : >98%(HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1G | 45 | In Stock |
|
Biological Information
-
Product NameDisulfiram
-
NoteResearch use only, not for human use.
-
Brief DescriptionDisulfiram is a specific inhibitor of aldehyde-dehydrogenase (ALDH1), used for the treatment of chronic alcoholism by producing an acute sensitivity to alcohol.
-
DescriptionDisulfiram is a specific inhibitor of aldehyde-dehydrogenase (ALDH1), used for the treatment of chronic alcoholism by producing an acute sensitivity to alcohol.
-
SynonymsNSC 25953; Tetraethylthiuram disulfide
-
PathwayMetabolic Enzyme/Protease
-
TargetDehydrogenase
-
RecptorALDH1; DBH
-
Research AreaMetabolic Disease
-
Indication——
Chemical Information
-
CAS Number97-77-8
-
Formula Weight296.54
-
Molecular FormulaC10H20N2S4
-
Purity>98%(HPLC)
-
SolubilityEthanol: 59 mg/mL (198.96 mM); DMSO: 59 mg/mL (198.96 mM)
-
SMILESS=C(SSC(N(CC)CC)=S)N(CC)CC
-
Chemical NameBis(diethylthiocarbamyl) disulfide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Mackenzie IS, et al. Arterioscler Thromb Vasc Biol. 2005 Sep; 25(9):1891-5.
molnova catalog
related products
-
CAY10566
CAY10566 shows excellent cellular activity in blocking the conversion of saturated long-chain fatty acid-CoAs (LCFA-CoAs) to monounsaturated LCFA-CoAs in HepG2 cells (IC50=7.9 nM or 6.8 nM). CAY10566 is a potent, orally bioavailable and selective stearoyl-CoA desaturase1 (SCD1) inhibitor with IC50s of 4.5 and 26 nM in mouse and human enzymatic assays, respectively.
-
GSK1940029
GSK1940029 is a stearoyl-coa desaturase (SCD) inhibitor.
-
G-749
G-749, a new-type FLT3 inhibitor, exhibits effective and sustained inhibition of the FLT3 wild type and mutants.
